Rapiblyk

Active Ingredient(s): Landiolol Hydrochloride
FDA Approved: * November 22, 2024
Pharm Company: * AOP ORPHAN
Category: Heart (Cardiac)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Rapiblyk 280 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 84381-110
Labeler:
Aop Orphan Pharmaceuticals Gmbh
Rapiblyk 280 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 87073-110
Labeler:
Aop Health Us, LLC